Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Heterologous Immunity”

45 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 45 results

Early research (Phase 1)WithdrawnNCT05167253
What this trial is testing

Evaluate the Ability of UB-612 COVID-19 Vaccine to Boost Immunity of Heterologous COVID-19 Vaccines.

Who this might be right for
COVID-19
United Biomedical Inc., Asia
Post-approval studies (Phase 4)Ended earlyNCT00126217
What this trial is testing

Revaccination of Young Children With Bacille Calmette Guerin (BCG) Vaccine

Who this might be right for
Malaria
Bandim Health Project 2,871
Post-approval studies (Phase 4)Study completedNCT03656198
What this trial is testing

Non-specific Effects of Rabies Vaccine

Who this might be right for
Influenza-like IllnessUpper Respiratory DiseaseDiarrhea+1 more
Ross University School of Veterinary Medicine 546
Very early researchStudy completedNCT05401448
What this trial is testing

Non-specific Effects of FLU-MMR Vaccines in Adults

Who this might be right for
COVID-19
Radboud University Medical Center 638
Post-approval studies (Phase 4)Study completedNCT00168558
What this trial is testing

Early Two-dose Measles Vaccination Trial

Who this might be right for
Measles
Bandim Health Project 5,879
Testing effectiveness (Phase 2)Study completedNCT07408297
What this trial is testing

Evaluating Safety and Immune Response of Janssen, Moderna, Pfizer/BNT, and Novavax COVID-19 Vaccines for Same and Mixed Boosters in Adolescents and Adults Aged 12-64 With and Without HIV in Kenya, DRC, and Rwanda

Who this might be right for
COVID -19SARS CoV 2 Infection
Victoria Biomedical Research Institute 1,919
Early research (Phase 1)Study completedNCT01379430
What this trial is testing

Safety and Immunogenicity of AdCh63 ME-TRAP and MVA ME-TRAP Vaccines in Malaria Endemic Areas

Who this might be right for
Malaria
University of Oxford 30
Post-approval studies (Phase 4)Study completedNCT04445428
What this trial is testing

OPV as Potential Protection Against COVID-19

Who this might be right for
Poliovirus Vaccine, OralCOVIDMortality+2 more
Bandim Health Project 3,729
Testing effectiveness (Phase 2)UnknownNCT05132855
What this trial is testing

The Immune Response of Heterologous Boost Third Dose of mRNA and Protein COVID-19 Vaccine

Who this might be right for
COVID-19Breakthrough Infection
Chang Gung Memorial Hospital 340
Early research (Phase 1)Study completedNCT00458120
What this trial is testing

Safety of and Immune Response to Two Different Dengue Virus Vaccines in Individuals Previously Immunized Against Dengue Virus

Who this might be right for
Dengue Hemorrhagic Fever
National Institute of Allergy and Infectious Diseases (NIAID) 36
Post-approval studies (Phase 4)Looking for participantsNCT04899765
What this trial is testing

Measles and BCG Vaccines for Mother and Child

Who this might be right for
Vaccine Preventable DiseaseMeaslesMother-Infant Interaction+1 more
Bandim Health Project 2,400
Large-scale testing (Phase 3)Study completedNCT04373291
What this trial is testing

Using BCG Vaccine to Protect Health Care Workers in the COVID-19 Pandemic

Who this might be right for
COVID-19Non-specific Effects of VaccinesMorbidity+2 more
Bandim Health Project 1,293
Not applicableStudy completedNCT01660854
What this trial is testing

Re-exposure of Human Volunteers to a Heterologous Strain of P. Falciparum Sporozoites

Who this might be right for
Malaria, Falciparum
Radboud University Medical Center 21
Early research (Phase 1)Study completedNCT02083887
What this trial is testing

A Phase I Study to Assess the Safety and Immunogenicity of ChAd63 ME-TRAP - MVA ME-TRAP Heterologous Prime-boost Vaccination Co-administered With EPI Vaccines in Gambian Infants

Who this might be right for
Malaria
University of Oxford 65
Post-approval studies (Phase 4)Study completedNCT03400878
What this trial is testing

Comparing Morbidity and Mortality Effects of Two Different Strains of BCG

Who this might be right for
Heterologous ImmunityInfant MorbidityInfant Mortality+3 more
Bandim Health Project 17,505
Large-scale testing (Phase 3)Ended earlyNCT05220397
What this trial is testing

Janssen Ad26.CoV2.S Vaccine Booster in Kidney Transplant Recipients

Who this might be right for
Kidney Transplant Recipient
Mark Stegall 468
Early research (Phase 1)Study completedNCT00961883
What this trial is testing

Safety of and Immune Response to Prime/Boost Vaccine Regimens in Healthy, HIV-1 Uninfected, Ad5 Seronegative Adults

Who this might be right for
HIV Infections
HIV Vaccine Trials Network 80
Post-approval studies (Phase 4)UnknownNCT05397678
What this trial is testing

Trial to Compare BCG-Bulgaria and BCG-Denmark

Who this might be right for
Death; NeonatalDeath, InfantMorbidity;Newborn+2 more
Bandim Health Project 15,000
Not applicableUnknownNCT05471167
What this trial is testing

Non-specific Effects of BCG in Under-five Children

Who this might be right for
Immunity, Heterologous
Universidade Nova de Lisboa 80,000
Early research (Phase 1)Study completedNCT00472719
What this trial is testing

Safety of and Immune Response to a DNA HIV Vaccine Followed By Boosting With One of Two Serotypes of Adenoviral Vector HIV Vaccine in Healthy Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 17
Load More Results